Hyperinsulinemia and Cancer Risk: A Potential Link Highlighted.

A recent article published in the Journal of Clinical Endocrinology & Metabolism discusses the potential role of hyperinsulinemia — a condition of chronically elevated insulin levels — in the development and progression of cancer.

Key observations

• Hyperinsulinemia is associated with increased cancer incidence and mortality, raising concerns beyond its metabolic effects.
• Mechanistic pathways potentially linking insulin excess to cancer include:
• Activation of insulin and IGF-1 receptors, promoting mitogenic and anti-apoptotic signaling.
• Upregulation of mTOR and PI3K pathways, key drivers of cell proliferation.
• Chronic inflammation and oxidative stress, creating a tumor-promoting environment.
• Experimental models show that insulin can directly stimulate tumor cell growth, while epidemiologic studies suggest a correlation between elevated insulin and higher risk of certain cancers, particularly colorectal, pancreatic, breast, and endometrial cancer.

Clinical implications

• These findings reinforce the importance of addressing insulin resistance and hyperinsulinemia not only for metabolic and cardiovascular health but also as a potential strategy for cancer prevention.
• Lifestyle interventions (weight reduction, dietary modification, exercise) and pharmacologic approaches (e.g., metformin, GLP-1 receptor agonists, SGLT2 inhibitors) may play a dual role in improving metabolic health and potentially lowering cancer risk .

Conclusion

Although causality has not yet been definitively proven, the accumulating evidence highlights hyperinsulinemia as a potential modifiable risk factor for cancer. The article emphasizes the need for longitudinal studies and mechanistic research to clarify the role of insulin in carcinogenesis and to guide preventive and therapeutic strategies.

Editorial note: This content was developed with the support of artificial intelligence technologies to optimize the writing and structuring of the information. All material was carefully reviewed, validated, and supplemented by human experts prior to publication, ensuring scientific accuracy and adherence to good editorial practices.

#Hyperinsulinemia #CancerRisk #Endocrinology #Metabolism #JCEM